Analyst stock forecast
Ovid Therapeutics Inc. Forecast: $5.69 Analyst Target
OVID has a $5.69 target, Strong Buy rating and 9 analysts. As of 2026-08-15.
Direct answer
Ovid Therapeutics Inc.'s average price target is $5.69.
The target implies +101.2% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +41.3%, the high target implies +218%, and the range spans 176.7% of the current price.
Forecast evidence checked August 15, 2026.
Get free Ovid Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.83
- Average price target
- $5.69
- High price target
- $9.00
- Low price target
- $4.00
- Low target gap
- +41.3%
- Target upside
- +101.2%
- High target gap
- +218%
- Target range width
- 176.7%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026